In silico subtractive genomics for target identification in human bacterial pathogens

Drug Development Research

Volumn 72, Issue 2, 2011, Pages 162-177

  Barh, Debmalya ^a,d   Tiwari, Sandeep ^b   Jain, Neha ^b   Ali, Amjad ^c   Santos, Anderson Rodrigues ^c   Misra, Amarendra Narayan ^d   Azevedo, Vasco ^c   Kumar, Anil ^b  

^a Institute of Integrative Omics and Applied Biotechnology IIOAB   (India)

^b DEVI AHILYA UNIVERSITY   (India)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d FAKIR MOHAN UNIVERSITY   (India)

Author keywords

bacterial pathogen; drug target; essential genes; subtractive genomics

Indexed keywords

AMIKACIN; AZITHROMYCIN; BCG VACCINE; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHOLERA VACCINE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DAPSONE; ERYTHROMYCIN; ETHAMBUTOL; FURAZOLIDONE; ISONIAZID; LATAMOXEF; MEROPENEM; METRONIDAZOLE; MEZLOCILLIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

AEROMONAS HYDROPHILA; ARTICLE; BACTERIAL GENETICS; CLOSTRIDIUM PERFRINGENS; COMPUTER MODEL; DRUG RESEARCH; DRUG TARGETING; GENOMICS; HELICOBACTER PYLORI; HUMAN; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIAE; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STREPTOCOCCUS PNEUMONIAE; SUBTRACTIVE GENOMICS; VIBRIO CHOLERAE;

EID: 79953863902     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20413     Document Type: Article

References (79)

1. Allsop AE., 1998. Bacterial genome sequencing and drug discovery. Curr Opin Biotechnol 9: 637-642. (Pubitemid 28558496)
2. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ., 1990. Basic local alignment search tool. J Mol Biol 215: 403-410.
3. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ., 1997. Gapped blast and psi-blast: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402. (Pubitemid 27359211)
4. Arias CA, Murray BE., 2009. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 360: 439-443.
5. Asif SM, Asad A, Faizan A, Anjali MS, Arvind A, Neelesh K, Hirdesh K, Sanjay K,. 2009. Dataset of potential targets for Mycobacterium tuberculosis H37Rv through comparative genome analysis. Bioinformation 4: 245-248.
6. Bairoch A, Apweiler R., 1997. The SWISS-PROT protein sequence data bank and its supplement TrEMBL. Nucleic Acids Res 25: 31-36. (Pubitemid 27303144)
7. Bambini S, Rappuoli R., 2009. The use of genomics in microbial vaccine development. Drug Discov Today 14: 252-260.
8. Barh D, Kumar A., 2009. In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol 9: 225-231.
9. Barh D, Misra AN., 2009. In silico identification of membrane associated candidate drug targets in Neisseria gonorrhoeae. Int J Integr Biol 6: 65-67.
10. Barh D, Kumar A, Misra AN., 2009. Genomic Target Database (GTD): a database of potential targets in human pathogenic bacteria. Bioinformation 4: 50-51.
11. Barh D, Misra AN, Kumar A, Azevedo V., 2010a. A novel strategy of epitope design in Neisseria gonorrhoeae. Bioinformation 5: 77-85.
12. Barh D, Misra AN, Kumar A., 2010b. In silico identification of dual ability of N. gonorrhoeae ddl for developing drug and vaccine against pathogenic Neisseria and other human pathogens. J Proteomics Bioinform 3:082-090.
13. Barinov A, Loux V, Hammani A, Nicolas P, Langella P, Ehrlich D, Maguin E, van de Guchte M., 2009. Prediction of surface exposed proteins in Streptococcus pyogenes, with a potential application to other Gram-positive bacteria. Proteomics 9: 61-73.
14. Bendtsen JD, Nielsen H, von Heijne G, Brunak S., 2004. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783-795. (Pubitemid 38829638)
15. Bernal A, Ear U, Kyrpides N., 2001. Genomes OnLine Database (GOLD): a monitor of genome projects world-wide. Nucleic Acids Res 29: 126-167.
16. Bhasin M, Garg A, Raghava GPS., 2005. PSLpred: prediction of subcellular localization of bacterial proteins. Bioinformatics 21: 2522-2524. (Pubitemid 40731613)
17. Bhavsar AP, Guttman JA, Finlay BB., 2007. Manipulation of host-cell pathways by bacterial pathogens. Nature 449: 827-834. (Pubitemid 47598623)
18. Bruccoleri RE, Dougherty TJ, Davison DB., 1998. Concordance analysis of microbial genomes. Nucleic Acids Res 26: 4482-4486. (Pubitemid 28442143)
19. Chan JN, Nislow C, Emili A., 2010. Recent advances and method development for drug target identification. Trends Pharmacol Sci 31: 82-88.
20. Chen L, Yang J, Yu J, Yao Z, Sun L, Shen Y, Jin Q., 2005. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res 33: 325-328.
21. Chetouani F, Glaser P, Kunst F., 2001. FindTarget: software for subtractive genome analysis. Microbiology 147: 2643-2649. (Pubitemid 32976305)
22. Chhabra V, Sharma P, Anant A, Deshmukh S, Kaushik H, Gopal K, Srivastava N, Sharma N, Garg LC., 2010. Identification and modeling of a drug target for Clostridium perfringens SM101. Bioinformation 4: 278-289.
23. Chong CE, Lim BS, Nathan S, Mohamed R., 2006. In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets. In Silico Biol 6: 341-346. (Pubitemid 44430622)
24. Dong QJ, Wang Q, Xin YN, Li N, Xuan SY., 2009. Comparative genomics of Helicobacter pylori. World J Gastroenterol 15: 3984-3991.
25. Downs DM., 2006. Understanding microbial metabolism. Annu Rev Microbiol 60: 533-559. (Pubitemid 44627960)
26. Dutta A, Singh SK, Ghosh P, Mukherjee R, Mitter S, Bandyopadhyay D., 2006. In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol 6: 43-47. (Pubitemid 43905155)
27. Fischbach MA, Walsh CT., 2009. Antibiotics for emerging pathogens. Science 28: 1089-1093.
28. Gardy JL, Laird MR, Chen F, Rey S, Walsh CJ, Ester M, Brinkman FSL., 2005. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21: 617-623. (Pubitemid 40424787)
29. Gupta SK, Singh S, Gupta MK, Pant KK, Seth PK., 2010. Identification of potential targets in Mycoplasma pneumoniae through subtractive genome analysis. J Antivir Antiretrovir 2:038-041.
30. Holman AG, Davis PJ, Foster JM, Carlow CK, Kumar S., 2009. Computational prediction of essential genes in an unculturable endosymbiotic bacterium, Wolbachia of Brugia malayi. BMC Microbiol 9: 243.
31. Hood DW., 1999. The utility of complete genome sequences in the study of pathogenic bacteria. Parasitology 118: S3-S9.
32. Huynen MA, Diaz-Lazcoz Y, Bork P., 1997. Differential genome display. Trends Genet 13: 389-390. (Pubitemid 127739571)
33. Huynen M, Dandekar T, Bork P., 1998. Differential genome analysis applied to the species-specific features of Helicobacter pylori. FEBS Lett 426: 1-5. (Pubitemid 28198144)
34. Imai K, Asakawa N, Tsuji T, Akazawa F, Ino A, Sonoyama M, Mitaku S., 2008. SOSUI-GramN: high performance prediction for sub-cellular localization of proteins in Gram-negative bacteria. Bioinformation 2: 417-421.
35. Ishii N, Robert M, Nakayama Y, Kanai A, Tomita M., 2004. Toward large-scale modeling of the microbial cell for computer simulation. J Biotechnol 113: 281-294. (Pubitemid 39237084)
36. Itaya M., 1995. An estimation of minimal genome size required for life. FEBS Lett 362: 257-260.
37. Ji Y., 2002. The role of genomics in the discovery of novel targets for antibiotic therapy. Pharmacogenomics 3: 315-323. (Pubitemid 34567569)
38. Jordan IK, Rogozin IB, Wolf YI, Koonin EV., 2002. Essential genes are more evolutionarily conserved than are nonessential genes in bacteria. Genome Res 12: 962-968. (Pubitemid 34662289)
39. Juncker AS, Willenbrock H, Von Heijne G, Brunak S, Nielsen H, Krogh A., 2003. Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci 12: 1652-1662. (Pubitemid 36910046)
40. Kobayashi K, Ehrlich SD, Albertini A, Amati G, Andersen KK, Arnaud M, Asai K, Ashikaga S, Aymerich S, Bessieres P, et al. 2003. Essential Bacillus subtilis genes. Proc Natl Acad Sci USA 100: 4678-4683. (Pubitemid 36457789)
41. Koonin EV, Tatusov RL, Galperin MY,. 1998. Beyond complete genomes: from sequence to structure and function. 8: 355-363.
42. Krause A, Haas SA, Coward E, Vingron M., 2002. SYSTERS, GeneNest, SpliceNest: exploring sequence space from genome to protein. Nucleic Acids Res 30: 299-300. (Pubitemid 34679568)
43. Kriventseva EV, Fleischmann W, Zdobnov EM Apweiler R., 2001. CluSTr: a database of clusters of SWISSPROT TrEMBL proteins. Nucleic Acids Res 29: 33-36. (Pubitemid 32054400)
44. Krogh A, Larsson B, von Heijne G, Sonnhammer EL., 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305: 567-580. (Pubitemid 33032862)
45. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921. (Pubitemid 32165345)
46. Lin J, Qian J., 2007. Systems biology approach to integrative comparative genomics. Expert Rev Proteomics 4: 107-119. (Pubitemid 46242106)
47. McDevitt D, Rosenberg M., 2001. Exploiting genomics to discover new antibiotics. Trends Microbiol 9: 611-617. (Pubitemid 33135418)
48. Meinke A, Henics T, Nagy E., 2004. Bacterial genomes pave the way to novel vaccines. Curr Opin Microbiol 7: 314-320. (Pubitemid 38758074)
49. Mills SD., 2006. When will the genomics investment pay off for antibacterial discovery? Biochem Pharmacol 30: 1096-1102.
50. Mushegian AR, Koonin EV., 1996. A minimal gene set for cellular life derived by comparison of complete bacterial genomes. Proc Natl Acad Sci USA 93: 10268-10273. (Pubitemid 26314611)
51. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M., 1999. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27: 29-34. (Pubitemid 29209394)
52. Owa T., 2007. Drug target validation and identification of secondary drug target effects using DNA microarrays. Tanpakushitsu Kakusan Koso 52: 1808-1809.
53. Pearson WR, Lipman DJ., 1988. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85: 2444-2448.
54. Perrière G, Duret L, Gouy M., 2000. HOBACGEN: database system for comparative genomics in bacteria. Genome Res 10: 379-385. (Pubitemid 30168670)
55. Perumal D, Lim CS, Sakharkar KR, Sakharkar MK., 2007. Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification. In Silico Biol 7: 453-465. (Pubitemid 351217190)
56. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL., 1996. Trends in infectious diseases mortality in the United States. JAMA 275: 189-193. (Pubitemid 26028558)
57. Plotkin SA., 2005. Why certain vaccines have been delayed or not developed at all. Health Aff (Millwood) 24: 631-634.
58. Pucci MJ., 2006. Use of genomics to select antibacterial targets. Biochem Pharmacol 71: 1066-1072.
59. Rappuoli R., 2000. Reverse vaccinology. Curr Opin Microbiol 3: 445-450.
60. Rathi B, Aditya N, Sarangi AN, Trivedi N., 2009. Genome subtraction for novel target definition in Salmonella typhi. Bioinformation 4: 143-150.
61. Sakharkar KR, Sakharkar MK, Chow VT., 2004. A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol 4: 355-360. (Pubitemid 39600481)
62. Sarangi AN, Aggarwal R, Rahman Q, Trivedi N., 2009. Subtractive genomics approach for in silico identification and characterization of novel drug targets in Neisseria meningitidis serogroup B. J Comput Sci Syst Biol 2: 255-258.
63. Serruto D, Rappuoli R., 2006. Post-genomic vaccine development. FEBS Lett 580: 2985-2992. (Pubitemid 43729171)
64. Shanmugam A, Natarajan J., 2010. Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification. Bioinformation 4: 392-395.
65. Shao Y, He X, Harrison EM, Tai C, Ou HY, Rajakumar K, Deng Z., 2010. mGenomeSubtractor: a web-based tool for parallel in silico subtractive hybridization analysis of multiple bacterial genomes. Nucleic Acids Res 38: 194-200.
66. Sharma V, Gupta P, Dixit A., 2008. In silico identification of putative drug targets from different metabolic pathways of Aeromonas hydrophila. In Silico Biol 8: 331-338.
67. Sibbald MJJB, van Dij JML., 2009. Secretome mapping in gram-positive pathogens. In:, Wooldridge K, editor. Bacterial secreted protein: secretory mechanisms and role in pathogenesis. Norfolk, UK: Caister Academic Press. p 193-225.
68. Simeone R, Bottai D, Brosch R., 2009. ESX/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 12: 4-10.
69. Singh NK, Selvam SM, Chakravarthy P., 2006. T-iDT: tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis. In Silico Biol 6: 485-493. (Pubitemid 47028641)
70. Singh S, Malik BK, Sharma DK., 2007. Metabolic pathway analysis of S. pneumoniae: an in silico approach towards drug-design. J Bioinform Comput Biol 5: 135-153. (Pubitemid 46705938)
71. Stavrinides J, McCann HC, Guttman DS., 2008. Host-pathogen interplay and the evolution of bacterial effectors. Cell Microbiol 10: 285-292.
72. Stumm G, Russ A, Nehls M., 2002. Deductive genomics: a functional approach to identify innovative drug targets in the post-genome era. Am J Pharmacogenom 2: 263-271. (Pubitemid 35429316)
73. Tatusov RL, Koonin EV, Lipman DJ., 1997. A genomic perspective on protein families. Science 278: 631-637. (Pubitemid 27464953)
74. Tatusov RL, Natale DA, Garkavtsev IV, Tatusova TA, Shankavaram UT, Rao BS, Kiryutin B, Galperin MY, Fedorova ND, Koonin EV., 2001. The COG database: new developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res 29: 22-28. (Pubitemid 32054398)
75. Thykaer J, Andersen MR, Baker SE., 2009. Essential pathway identification: from in silico analysis to potential antifungal targets in Aspergillus fumigatus. Med Mycol 47: S80-S87.
76. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, et al. 2001. The sequence of the human genome. Science 291: 1304-1351. (Pubitemid 32173090)
77. Yona G, Linial N, Linial M., 1999. ProtoMap: automatic classification of protein sequences, a hierarchy of protein families, and local maps of the protein space. Proteins 37: 360-378. (Pubitemid 29519727)
78. Yu CS, Lin CJ, Hwang JK., 2004. Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci 13: 1402-1406.
79. Zhang R, Ou HY, Zhang CT., 2004. DEG: a database of essential genes. Nucleic Acids Res 32: D271-D272. (Pubitemid 38081654)